Natera, Inc. Profile Avatar - Palmy Investing

Natera, Inc.

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as tw…
Medical - Diagnostics & Research
US, San Carlos [HQ]

Balance Sheet

11 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
59.00 123.00 265.00 210.00 178.00 268.00 582.00 932.00 1,236.00 1,394.00 1,457.00
Current
49.00 106.00 250.00 174.00 144.00 240.00 523.00 862.00 1,093.00 1,211.00 1,258.00
Non Current
10.00 17.00 14.00 36.00 33.00 27.00 59.00 69.00 143.00 182.00 198.00
Liabilities
231.00 294.00 80.00 104.00 189.00 236.00 303.00 445.00 583.00 688.00 691.00
Current
23.00 29.00 80.00 96.00 105.00 113.00 179.00 199.00 218.00 310.00 307.00
Non Current
207.00 265.00 - - 7.00 83.00 122.00 124.00 246.00 364.00 378.00 384.00
Equity
-171.00 -171.00 184.00 106.00 -10.00 32.00 278.00 486.00 653.00 705.00 765.00
Stockholders' Equity
-171.00 -171.00 184.00 106.00 -10.00 32.00 278.00 486.00 653.00 705.00 765.00
Retained Earnings
-174.00 -179.00 -250.00 -345.00 -482.00 -574.00 -699.00 -929.00 -1,394.00 -1,942.00 -2,377.00
Common Stock
- - - - - - - - - - - - - - - - - - - - - -
Preferred Stock
- - - - 265.00 - - - - - - - - - - - - - - - -
Profit
-37.00 -5.00 -70.00 -95.00 -136.00 -128.00 -124.00 -229.00 -471.00 -547.00 -434.00
Dividends
- - - - - - - - - - - - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
7.00 18.00 171.00 453.00 472.00 607.00 976.00 1,411.00 2,050.00 2,664.00 3,145.00
Loss Other Compr. Income
-4.00 -9.00 -1.00 - - - - - - - - 4.00 -2.00 -16.00 -3.00
End of NTRA's Analysis
CIK: 1604821 CUSIP: 632307104 ISIN: US6323071042 LEI: - UEI: -
Secondary Listings
NTRA has no secondary listings inside our databases.